Article info

PDF

Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literature

Authors

  • Lian Beijers University of Groningen, University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), Groningen, The Netherlands. PubMed articlesGoogle scholar articles
  • Bertus F Jeronimus University of Groningen, University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), Groningen, The Netherlands. University of Groningen, Department of Developmental Psychology, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Erick H Turner Behavioral Health and Neurosciences Division, VA Portland Health Care System, Portland, Oregon, USA Departments of Psychiatry and Pharmacology, Oregon Health & Science University, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Peter de Jonge University of Groningen, University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), Groningen, The Netherlands. University of Groningen, Department of Developmental Psychology, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Annelieke M Roest University of Groningen, University Medical Center Groningen, Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), Groningen, The Netherlands. PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bertus F Jeronimus; b.f.jeronimus{at}rug.nl
View Full Text

Citation

Beijers L, Jeronimus BF, Turner EH, et al
Spin in RCTs of anxiety medication with a positive primary outcome: a comparison of concerns expressed by the US FDA and in the published literature

Publication history

  • Received 1 June 2016
  • Revised 28 November 2016
  • Accepted 6 February 2017
  • Published online 29 March 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.